Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform.

This work describes the development and validation of a patient-specific Monte Carlo internal dosimetry platform called RAPID (Radiopharmaceutical Assessment Platform for Internal Dosimetry). RAPID utilizes serial PET/CT or SPECT/CT images to calculate voxelized three-dimensional (3D) internal dose distributions with the Monte Carlo code Geant4. RAPID's dosimetry calculations were benchmarked against previously published S-values and specific absorbed fractions (SAFs) calculated for monoenergetic photon and electron sources within the Zubal phantom and for S-values calculated for a variety of radionuclides within spherical tumor phantoms with sizes ranging from 1 to 1000 g. The majority of the S-values and SAFs calculated in the Zubal Phantom were within 5% of the previously published values with the exception of a few 10 keV photon SAFs that agreed within 10%, and one value within 16%. The S-values calculated in the spherical tumor phantoms agreed within 2% for 177Lu, 131I, 125I, 18F, and 64Cu, within 3.5% for 211At and 213Bi, within 6.5% for 153Sm, 111In, 89Zr, and 223Ra, and within 9% for 90Y, 68Ga, and 124I. In conclusion, RAPID is capable of calculating accurate internal dosimetry at the voxel-level for a wide variety of radionuclides and could be a useful tool for calculating patient-specific 3D dose distributions.

[1]  Lauren B. Smith,et al.  Tumor-Absorbed Dose Predicts Progression-Free Survival Following 131I-Tositumomab Radioimmunotherapy , 2014, The Journal of Nuclear Medicine.

[2]  Anna Celler,et al.  Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques. , 2014, Medical physics.

[3]  M. Kessler.  Image registration and data fusion in radiation therapy. , 2006, The British journal of radiology.

[4]  M. Graham,et al.  Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Pierre Vera,et al.  Voxeldoes: a computer program for 3-D dose calculation in therapeutic nuclear medicine. , 2003, Cancer biotherapy & radiopharmaceuticals.

[6]  D. E. Wessol,et al.  Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system , 2004, Physics in medicine and biology.

[7]  K. Kearfott,et al.  Comparison of I-131 radioimmunotherapy tumor dosimetry: unit density sphere model versus patient-specific Monte Carlo calculations. , 2011, Cancer biotherapy & radiopharmaceuticals.

[8]  M Bardiès,et al.  Validation of a personalized dosimetric evaluation tool (Oedipe) for targeted radiotherapy based on the Monte Carlo MCNPX code , 2006, Physics in medicine and biology.

[9]  W. Burchert,et al.  Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  T. Bortfeld,et al.  Correlation between CT numbers and tissue parameters needed for Monte Carlo simulations of clinical dose distributions. , 2000, Physics in medicine and biology.

[11]  Joshua Grimes,et al.  JADA: a graphical user interface for comprehensive internal dose assessment in nuclear medicine. , 2013, Medical physics.

[12]  M G Stabin,et al.  Monte Carlo MCNP-4B-based absorbed dose distribution estimates for patient-specific dosimetry. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  George Sgouros,et al.  Calculation of the biological effective dose for piecewise defined dose-rate fits. , 2009, Medical physics.

[14]  S Marcatili,et al.  Development and validation of RAYDOSE: a Geant4-based application for molecular radiotherapy , 2013, Physics in medicine and biology.

[15]  L Maigne,et al.  Validation of a dose deposited by low-energy photons using GATE/GEANT4 , 2008, Physics in medicine and biology.

[16]  R. Abramson,et al.  VIDA: a voxel-based dosimetry method for targeted radionuclide therapy using Geant4. , 2015, Cancer biotherapy & radiopharmaceuticals.

[17]  A. Hogg,et al.  An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging. , 2013, Medical physics.

[18]  N Lanconelli,et al.  Differences among Monte Carlo codes in the calculations of voxel S values for radionuclide targeted therapy and analysis of their impact on absorbed dose evaluations. , 2009, Medical physics.

[19]  Yuni K. Dewaraja,et al.  Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin’s lymphoma , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  B. Faddegon,et al.  The accuracy of EGSnrc, Geant4 and PENELOPE Monte Carlo systems for the simulation of electron scatter in external beam radiotherapy , 2009, Physics in medicine and biology.

[21]  Michael Ljungberg,et al.  177Lu‐[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy , 2010, Cancer.

[22]  N. Lanconelli,et al.  Quantitative comparison between the commercial software STRATOS(®) by Philips and a homemade software for voxel-dosimetry in radiopeptide therapy. , 2015, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[23]  Rachida Lebtahi,et al.  Study of the Impact of Tissue Density Heterogeneities on 3-Dimensional Abdominal Dosimetry: Comparison Between Dose Kernel Convolution and Direct Monte Carlo Methods , 2013, The Journal of Nuclear Medicine.

[24]  M Bardiès,et al.  Model-based versus specific dosimetry in diagnostic context: comparison of three dosimetric approaches. , 2015, Medical physics.

[25]  Manuel Bardiès,et al.  OEDIPE: a personalized dosimetric tool associating voxel-based models with MCNPX. , 2005, Cancer biotherapy & radiopharmaceuticals.

[26]  Alain Pitiot,et al.  Piecewise affine registration of biological images for volume reconstruction , 2006, Medical Image Anal..

[27]  Wesley E. Bolch,et al.  MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of Nomenclature , 2009, Journal of Nuclear Medicine.

[28]  G Sgouros,et al.  Implementation and evaluation of patient-specific three-dimensional internal dosimetry. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  Jacques Barbet,et al.  Effect of Patient Morphology on Dosimetric Calculations for Internal Irradiation as Assessed by Comparisons of Monte Carlo Versus Conventional Methodologies , 2009, Journal of Nuclear Medicine.

[30]  S. Larson,et al.  Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  M G Stabin,et al.  Absorbed fractions in a voxel-based phantom calculated with the MCNP-4B code. , 2000, Medical physics.

[32]  H. Yoriyaz,et al.  Physical models, cross sections, and numerical approximations used in MCNP and GEANT4 Monte Carlo codes for photon and electron absorbed fraction calculation. , 2009, Medical physics.

[33]  Yuni K Dewaraja,et al.  131I-Tositumomab Radioimmunotherapy: Initial Tumor Dose–Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling , 2010, Journal of Nuclear Medicine.

[34]  K. Koral,et al.  Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  J Y Wong,et al.  A radionuclide therapy treatment planning and dose estimation system. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  R Mohan,et al.  Treatment planning for internal radionuclide therapy: three-dimensional dosimetry for nonuniformly distributed radionuclides. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  A. Ahnesjö.  Collapsed cone convolution of radiant energy for photon dose calculation in heterogeneous media. , 1989, Medical physics.

[38]  Rachida Lebtahi,et al.  A new approach for dose calculation in targeted radionuclide therapy (TRT) based on collapsed cone superposition: validation with 90Y , 2014, Physics in medicine and biology.

[39]  K. Koral,et al.  Recovery of total I-131 activity within focal volumes using SPECT and 3D OSEM , 2007, Physics in medicine and biology.

[40]  P B Hoffer,et al.  Computerized three-dimensional segmented human anatomy. , 1994, Medical physics.

[41]  Eric C Frey,et al.  Tumor Dosimetry and Response for 153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Therapy of High-Risk Osteosarcoma , 2012, The Journal of Nuclear Medicine.

[42]  A. Bockisch,et al.  Optimized 124I PET Dosimetry Protocol for Radioiodine Therapy of Differentiated Thyroid Cancer , 2008, Journal of Nuclear Medicine.

[43]  Maggie A Flower,et al.  RMDP: a dedicated package for 131I SPECT quantification, registration and patient-specific dosimetry. , 2003, Cancer biotherapy & radiopharmaceuticals.

[44]  Michael G Stabin,et al.  OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.